Publications
2024
Metabolic syndrome traits differentially and cumulatively influence micro- and macrovascular disease risk in patients with MASLD.
Henney, A. E., Riley, D. R., Hydes, T. J., Anson, M., Ibarburu, G. H., Zhao, S. S., . . . Alam, U. (2024). Metabolic syndrome traits differentially and cumulatively influence micro- and macrovascular disease risk in patients with MASLD.. Liver international : official journal of the International Association for the Study of the Liver. doi:10.1111/liv.16086
Sodium-glucose cotransporter 2 inhibitors reduce the risk of incident type 2 diabetes in people with heart failure without diabetes: An analysis of real-world, cohort data.
Henney, A. E., Riley, D. R., Heague, M., Hydes, T. J., Anson, M., Alam, U., & Cuthbertson, D. J. (2024). Sodium-glucose cotransporter 2 inhibitors reduce the risk of incident type 2 diabetes in people with heart failure without diabetes: An analysis of real-world, cohort data.. Diabetes, obesity & metabolism, 26(10), 4665-4673. doi:10.1111/dom.15833
The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes.
Riley, D. R., Hydes, T., Hernadez, G., Zhao, S. S., Alam, U., & Cuthbertson, D. J. (2024). The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes.. Liver international : official journal of the International Association for the Study of the Liver. doi:10.1111/liv.16016
Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility.
Henry-Blake, C., Balachandrakumar, V., Kassab, M., Devonport, J., Matthews, C., Fox, J., . . . Cross, T. J. S. (2024). Lower hepatocellular carcinoma surveillance in metabolic dysfunction-associated steatotic liver disease: Impact on treatment eligibility.. Journal of gastroenterology and hepatology. doi:10.1111/jgh.16727
Liver Fibrosis Assessed Via Noninvasive Tests Is Associated With Incident Heart Failure in a General Population Cohort.
Hydes, T. J., Kennedy, O. J., Glyn-Owen, K., Buchanan, R., Parkes, J., Cuthbertson, D. J., . . . Byrne, C. D. (2024). Liver Fibrosis Assessed Via Noninvasive Tests Is Associated With Incident Heart Failure in a General Population Cohort.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 22(8), 1657-1667. doi:10.1016/j.cgh.2024.03.045
Risk of type 2 diabetes, MASLD and cardiovascular disease in people living with polycystic ovary syndrome.
Henney, A. E., Gillespie, C. S., Lai, J. Y. M., Schofield, P., Riley, D. R., Caleyachetty, R., . . . Cuthbertson, D. J. (2024). Risk of type 2 diabetes, MASLD and cardiovascular disease in people living with polycystic ovary syndrome.. The Journal of clinical endocrinology and metabolism, dgae481. doi:10.1210/clinem/dgae481
Denosumab, for osteoporosis, reduces the incidence of type 2 diabetes, risk of foot ulceration and all-cause mortality in adults, compared with bisphosphonates: An analysis of real-world, cohort data, with a systematic review and meta-analysis.
Henney, A. E., Riley, D. R., O'Connor, B., Hydes, T. J., Anson, M., Zhao, S. S., . . . Cuthbertson, D. J. (2024). Denosumab, for osteoporosis, reduces the incidence of type 2 diabetes, risk of foot ulceration and all-cause mortality in adults, compared with bisphosphonates: An analysis of real-world, cohort data, with a systematic review and meta-analysis.. Diabetes, obesity & metabolism. doi:10.1111/dom.15708
Risk of adverse events in anticoagulated patients with atrial fibrillation and non-alcoholic fatty liver disease.
Bucci, T., Nabrdalik, K., Baratta, F., Pastori, D., Pignatelli, P., Hydes, T., . . . Lip, G. Y. H. (2024). Risk of adverse events in anticoagulated patients with atrial fibrillation and non-alcoholic fatty liver disease.. The Journal of clinical endocrinology and metabolism, dgae394. doi:10.1210/clinem/dgae394
Effect of a Low-Calorie Dietary Intervention on Liver Health and Body Weight in Adults with Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Overweight/Obesity: A Systematic Review and Meta-Analysis
Dobbie, L. J., Burgess, J., Hamid, A., Nevitt, S. J., Hydes, T. J., Alam, U., & Cuthbertson, D. J. (n.d.). Effect of a Low-Calorie Dietary Intervention on Liver Health and Body Weight in Adults with Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Overweight/Obesity: A Systematic Review and Meta-Analysis. Nutrients, 16(7), 1030. doi:10.3390/nu16071030
Ultra‐processed food and non‐communicable diseases in the United Kingdom: A narrative review and thematic synthesis of literature
Henney, A. E., Gillespie, C. S., Alam, U., Hydes, T. J., Boyland, E., & Cuthbertson, D. J. (2024). Ultra‐processed food and non‐communicable diseases in the United Kingdom: A narrative review and thematic synthesis of literature. Obesity Reviews. doi:10.1111/obr.13682
High intake of ultra-processed food is associated with dementia in adults: a systematic review and meta-analysis of observational studies.
Henney, A. E., Gillespie, C. S., Alam, U., Hydes, T. J., Mackay, C. E., & Cuthbertson, D. J. (2024). High intake of ultra-processed food is associated with dementia in adults: a systematic review and meta-analysis of observational studies.. Journal of neurology, 271(1), 198-210. doi:10.1007/s00415-023-12033-1
The independent and joint risks of alcohol consumption, smoking, and excess weight on morbidity and mortality: a systematic review and meta-analysis exploring synergistic associations
Burton, R., Fryers, P. T., Sharpe, C., Clarke, Z., Henn, C., Hydes, T., . . . Sheron, N. (2024). The independent and joint risks of alcohol consumption, smoking, and excess weight on morbidity and mortality: a systematic review and meta-analysis exploring synergistic associations. Public Health, 226, 39-52. doi:10.1016/j.puhe.2023.10.035
2023
P30 Correlation between HbA1C and liver stiffness measurements in people with type 2 diabetes and non-alcoholic fatty liver disease
Li Zhi, P. K., Sieberhagen, C., Cuthbertson, D. J., & Hydes, T. (2023). P30 Correlation between HbA1C and liver stiffness measurements in people with type 2 diabetes and non-alcoholic fatty liver disease. In Poster presentations (pp. A31.2-A32). BMJ Publishing Group Ltd and British Society of Gastroenterology. doi:10.1136/gutjnl-2023-basl.46
National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022
Li, W., Sheridan, D., McPherson, S., Alazawi, W., Abeysekera, K., Marjot, T., . . . Olsen, K. (2023). National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022. JHEP Reports, 5(12), 100897. doi:10.1016/j.jhepr.2023.100897
Liver fibrosis assessed using non-invasive markers and genetic polymorphisms (<i>PNPLA3</i>and<i>TM6SF2</i>) predisposing to liver fibrosis, is associated with hospitalization or death from heart failure: a prospective UK Biobank study
Mendelian randomisation reveals Sodium-glucose Cotransporter-1 inhibition's potential in reducing Non-Alcoholic Fatty Liver Disease risk
Dobbie, L. J., Cuthbertson, D. J., Hydes, T. J., Alam, U., & Zhao, S. S. (2023). Mendelian randomisation reveals Sodium-glucose Cotransporter-1 inhibition's potential in reducing Non-Alcoholic Fatty Liver Disease risk. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 188(6), K33-K37. doi:10.1093/ejendo/lvad068
Exploration of the lack of systematic surveillance for hepatocellular carcinoma for patients with non-alcoholic fatty liver disease
Hydes, T., Blake, C. H., Kassab, M., Matthews, C., Kumar, V., Baggus, E., . . . Cross, T. (2023). Exploration of the lack of systematic surveillance for hepatocellular carcinoma for patients with non-alcoholic fatty liver disease. Journal of Hepatology, 78, S521-S522. doi:10.1016/s0168-8278(23)01278-3
Pilot results for a multidisciplinary community metabolic liver clinic
Hydes, T., Sieberhagen, C., Merrimen, M., Millard, L., Riley, D., & Cuthbertson, D. (2023). Pilot results for a multidisciplinary community metabolic liver clinic. Journal of Hepatology, 78, S617. doi:10.1016/s0168-8278(23)01941-4
The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank
Hydes, T. J., Kennedy, O. J., Buchanan, R., Cuthbertson, D. J., Parkes, J., Fraser, S. D. S., & Roderick, P. (n.d.). The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank. BMC Medicine, 21(1). doi:10.1186/s12916-023-02891-x
Ultra-Processed Food Intake Is Associated with Non-Alcoholic Fatty Liver Disease in Adults: A Systematic Review and Meta-Analysis
Henney, A. E., Gillespie, C. S., Alam, U., Hydes, T. J., & Cuthbertson, D. J. (n.d.). Ultra-Processed Food Intake Is Associated with Non-Alcoholic Fatty Liver Disease in Adults: A Systematic Review and Meta-Analysis. Nutrients, 15(10), 2266. doi:10.3390/nu15102266
Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis.
Dobbie, L. J., Pittam, B., Zhao, S. S., Alam, U., Hydes, T. J., Barber, T. M., & Cuthbertson, D. J. (2023). Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis.. Human reproduction (Oxford, England), dead053. doi:10.1093/humrep/dead053
Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease
Hydes, T. J., Lip, G. Y. H., & Lane, D. A. (2023). Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease. Circulation, 147(10), 795-797. doi:10.1161/circulationaha.122.063195
Ultrasonography in surveillance for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
Hydes, T. J., Cuthbertson, D. J., Palmer, D. H., Elshaarawy, O., Johnson, P. J., Fernando, R., & Cross, T. J. (2023). Ultrasonography in surveillance for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. HEPATOMA RESEARCH, 9. doi:10.20517/2394-5079.2022.97
2022
LACK OF NAFLD-RELATED HEPATOCELLULAR CARCINOMA SURVEILLANCE MAY EXPLAIN MORE ADVANCED STAGE AT DIAGNOSIS AND WORSE MEDIAN SURVIVAL
Hydes, T., Matthews, C., Kumar, V., Kassab, M., Blake, C. H., Baggus, E., . . . Cross, T. (2022). LACK OF NAFLD-RELATED HEPATOCELLULAR CARCINOMA SURVEILLANCE MAY EXPLAIN MORE ADVANCED STAGE AT DIAGNOSIS AND WORSE MEDIAN SURVIVAL. In GUT Vol. 71 (pp. A46-A47). doi:10.1136/gutjnl-2022-BASL.72
OP01 High prevalence rates of unaddressed cardiometabolic risk and multi-morbidity in patients with non-alcoholic fatty liver disease
Ginige, A., Allen-Griffiths, S., Healy, K., Matthews, C., Sieberhagen, C., Cuthbertson, D., & Hydes, T. (2022). OP01 High prevalence rates of unaddressed cardiometabolic risk and multi-morbidity in patients with non-alcoholic fatty liver disease. In Abstracts (pp. A11.1-A11). BMJ Publishing Group Ltd and British Society of Gastroenterology. doi:10.1136/gutjnl-2022-basl.14
The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective study using UK Biobank data
Hydes, T., Kennedy, O., Buchanan, R., Cuthbertson, D., Parkes, J., Fraser, S., & Roderick, P. (2022). The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective study using UK Biobank data. Journal of Hepatology, 77, S42. doi:10.1016/s0168-8278(22)00494-9
The Impact of the COVID-19 Pandemic on Mobility Trends and the Associated Rise in Population-Level Physical Inactivity: Insights From International Mobile Phone and National Survey Data
Dobbie, L. J., Hydes, T. J., Alam, U., Tahrani, A., & Cuthbertson, D. J. (n.d.). The Impact of the COVID-19 Pandemic on Mobility Trends and the Associated Rise in Population-Level Physical Inactivity: Insights From International Mobile Phone and National Survey Data. Frontiers in Sports and Active Living, 4. doi:10.3389/fspor.2022.773742
The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival
Hydes, T. J., Cuthbertson, D. J., Graef, S., Berhane, S., Teng, M., Skowronska, A., . . . Johnson, P. J. (2022). The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival. Clinical Therapeutics. doi:10.1016/j.clinthera.2021.12.011
2021
Low Screening Rates Despite a High Prevalence of Significant Liver Fibrosis in People with Diabetes from Primary and Secondary Care
Dobbie, L. J., Kassab, M., Davison, A. S., Grace, P., Cuthbertson, D. J., & Hydes, T. J. (2021). Low Screening Rates Despite a High Prevalence of Significant Liver Fibrosis in People with Diabetes from Primary and Secondary Care. JOURNAL OF CLINICAL MEDICINE, 10(24). doi:10.3390/jcm10245755
Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease
Brown, E., Hydes, T., Hamid, A., & Cuthbertson, D. J. (2021). Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver Disease. CLINICAL THERAPEUTICS, 43(9), 1476-1504. doi:10.1016/j.clinthera.2021.07.013
Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications
Hydes, T., Brown, E., Hamid, A., Bateman, A. C., & Cuthbertson, D. J. (2021). Current and Emerging Biomarkers and Imaging Modalities for Nonalcoholic Fatty Liver Disease: Clinical and Research Applications. Clinical Therapeutics. doi:10.1016/j.clinthera.2021.07.012
Validation of the liver traffic light test as a predictive model for survival and development of liver-related events
Sylvester, R., Hydes, T. J., Hales, A., Williams, R., & Sheron, N. (2021). Validation of the liver traffic light test as a predictive model for survival and development of liver-related events. JGH OPEN, 5(5), 549-557. doi:10.1002/jgh3.12460
The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?
Hydes, T., Alam, U., & Cuthbertson, D. J. (2021). The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?. Frontiers in Nutrition, 8, 640557. doi:10.3389/fnut.2021.640557
Can routine blood tests be modelled to detect advanced liver disease in the community: model derivation and validation using UK primary and secondary care data
Hydes, T., Moore, M., Stuart, B., Kim, M., Su, F., Newell, C., . . . Sheron, N. (2021). Can routine blood tests be modelled to detect advanced liver disease in the community: model derivation and validation using UK primary and secondary care data. BMJ OPEN, 11(2). doi:10.1136/bmjopen-2020-044952
A spotlight on natural killer cells in primary biliary cholangitis
Hydes, T., & Khakoo, S. I. (2021). A spotlight on natural killer cells in primary biliary cholangitis. JOURNAL OF HEPATOLOGY, 74(1), 254-255. doi:10.1016/j.jhep.2020.08.024
2020
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
Hydes, T. J., Ravi, S., Loomba, R., & Gray, M. E. (2020). Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH. CLINICAL AND MOLECULAR HEPATOLOGY, 26(4), 383-400. doi:10.3350/cmh.2020.0067
Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease
Hydes, T., Buchanan, R., Kennedy, O. J., Fraser, S., Parkes, J., & Roderick, P. (2020). Systematic review of the impact of non-alcoholic fatty liver disease on mortality and adverse clinical outcomes for individuals with chronic kidney disease. BMJ OPEN, 10(9). doi:10.1136/bmjopen-2020-040970
Mechanisms, screening modalities and treatment options for individuals with non‐alcoholic fatty liver disease and type 2 diabetes
Hydes, T. J., Summers, N., Brown, E., Alam, U., Thomaides-Brears, H., Wilding, J. P. H., & Cuthbertson, D. J. (2020). Mechanisms, screening modalities and treatment options for individuals with non‐alcoholic fatty liver disease and type 2 diabetes. Diabetic Medicine. doi:10.1111/dme.14356
Tu1736 INCREASED PREVALENCE OF METABOLIC SYNDROME AMONG PATIENTS WITH GASTRIC ANTRAL VASCULAR ECTASIA IN A CIRRHOTIC COHORT
Jariwala, R., Alkurdi, B., Li, P., Hydes, T., Peter, S., & Shoreibah, M. (2020). Tu1736 INCREASED PREVALENCE OF METABOLIC SYNDROME AMONG PATIENTS WITH GASTRIC ANTRAL VASCULAR ECTASIA IN A CIRRHOTIC COHORT. Gastroenterology, 158(6), S-1475. doi:10.1016/s0016-5085(20)34348-1
Tu1749 GASTRIC ANTRAL VASCULAR ECTASIA (GAVE): A FREQUENTLY MISSED DIAGNOSIS
Jariwala, R., Alkurdi, B., Li, P., Ravi, S., Peter, S., Hydes, T., & Shoreibah, M. (2020). Tu1749 GASTRIC ANTRAL VASCULAR ECTASIA (GAVE): A FREQUENTLY MISSED DIAGNOSIS. Gastroenterology, 158(6), S-1480. doi:10.1016/s0016-5085(20)34361-4
Exploring the gap in the public's understanding of the links between alcohol and cancer
Hydes, T. J., Williams, R., & Sheron, N. (2020). Exploring the gap in the public's understanding of the links between alcohol and cancer. CLINICAL MEDICINE, 20(1), 4-7. doi:10.7861/clinmed.ed.20.1.2
GASTRIC ANTRAL VASCULAR ECTASIA (GAVE): A FREQUENTLY MISSED DIAGNOSIS
Jariwala, R., Alkurdi, B., Li, P., Ravi, S., Peter, S., Hydes, T., & Shoreibah, M. (2020). GASTRIC ANTRAL VASCULAR ECTASIA (GAVE): A FREQUENTLY MISSED DIAGNOSIS. In GASTROENTEROLOGY Vol. 158 (pp. S1480). Retrieved from https://www.webofscience.com/
GASTRIC ANTRAL VASCULAR ECTASIA (GAVE): A FREQUENTLY MISSED DIAGNOSIS
Jariwala, R., Alkurdi, B., Li, P., Ravi, S., Peter, S., Hydes, T., & Shoreibah, M. (2020). GASTRIC ANTRAL VASCULAR ECTASIA (GAVE): A FREQUENTLY MISSED DIAGNOSIS. In JOURNAL OF GENERAL INTERNAL MEDICINE Vol. 35 (pp. S137). Retrieved from https://www.webofscience.com/
INCREASED PREVALENCE OF METABOLIC SYNDROME AMONG PATIENTS WITH GASTRIC ANTRAL VASCULAR ECTASIA IN A CIRRHOTIC COHORT
Jariwala, R., Alkurdi, B., Li, P., Hydes, T., Peter, S., & Shoreibah, M. (2020). INCREASED PREVALENCE OF METABOLIC SYNDROME AMONG PATIENTS WITH GASTRIC ANTRAL VASCULAR ECTASIA IN A CIRRHOTIC COHORT. In JOURNAL OF GENERAL INTERNAL MEDICINE Vol. 35 (pp. S175-S176). Retrieved from https://www.webofscience.com/
INCREASED PREVALENCE OF METABOLIC SYNDROME AMONG PATIENTS WITH GASTRIC ANTRAL VASCULAR ECTASIA IN A CIRRHOTIC COHORT
Jariwala, R., Alkurdi, B., Li, P., Hydes, T., Peter, S., & Shoreibah, M. (2020). INCREASED PREVALENCE OF METABOLIC SYNDROME AMONG PATIENTS WITH GASTRIC ANTRAL VASCULAR ECTASIA IN A CIRRHOTIC COHORT. In GASTROENTEROLOGY Vol. 158 (pp. S1475). Retrieved from https://www.webofscience.com/
2019
Constitutive Activation of Natural Killer Cells in Primary Biliary Cholangitis
Hydes, T. J., Blunt, M. D., Naftel, J., Vallejo, A. F., Seumois, G., Wang, A., . . . Khakoo, S. I. (2019). Constitutive Activation of Natural Killer Cells in Primary Biliary Cholangitis. FRONTIERS IN IMMUNOLOGY, 10. doi:10.3389/fimmu.2019.02633
A comparison of gender-linked population cancer risks between alcohol and tobacco: how many cigarettes are there in a bottle of wine?
Hydes, T. J., Burton, R., Inskip, H., Bellis, M. A., & Sheron, N. (2019). A comparison of gender-linked population cancer risks between alcohol and tobacco: how many cigarettes are there in a bottle of wine?. BMC PUBLIC HEALTH, 19. doi:10.1186/s12889-019-6576-9
Treating alcohol-related liver disease from a public health perspective
Hydes, T., Gilmore, W., Sheron, N., & Gilmore, I. (2019). Treating alcohol-related liver disease from a public health perspective. JOURNAL OF HEPATOLOGY, 70(2), 223-236. doi:10.1016/j.jhep.2018.10.036
CONSTITUTIVE DYSFUNCTION OF NATURAL KILLER CELLS IN PRIMARY BILIARY CHOLANGITIS
Hydes, T. J., Blunt, M. D., Naftel, J., Vallejo, A., Seumois, G., Wang, A., . . . Khakoo, S. I. (2019). CONSTITUTIVE DYSFUNCTION OF NATURAL KILLER CELLS IN PRIMARY BILIARY CHOLANGITIS. In HEPATOLOGY Vol. 70 (pp. 789A). Retrieved from https://www.webofscience.com/
OBETICHOLIC ACID AND BEZAFIBRATE IN PRIMARY BILIARY CHOLANGITIS: A COMPARATIVE EVALUATION OF EFFICACY THROUGH REAL WORLD CLINICAL PRACTICE
Culver, E., Hayden, J., Thorburn, D., Marshall, A., Aspinall, R., Dimmer, A., . . . Trivedi, P. (2019). OBETICHOLIC ACID AND BEZAFIBRATE IN PRIMARY BILIARY CHOLANGITIS: A COMPARATIVE EVALUATION OF EFFICACY THROUGH REAL WORLD CLINICAL PRACTICE. In HEPATOLOGY Vol. 70 (pp. 770A). Retrieved from https://www.webofscience.com/
2018
National Early Warning Score Accurately Discriminates the Risk of Serious Adverse Events in Patients With Liver Disease
Hydes, T. J., Meredith, P., Schmidt, P. E., Smith, G. B., Prytherch, D. R., & Aspinall, R. J. (2018). National Early Warning Score Accurately Discriminates the Risk of Serious Adverse Events in Patients With Liver Disease. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 16(10), 1657-+. doi:10.1016/j.cgh.2017.12.035
Hypersensitivity and constitutive activation of the IL-12/STAT4 pathway in NK cells in Primary Biliary Cholangitis: A novel mechanism
Hydes, T., Khakoo, S., & Naftel, J. (2018). Hypersensitivity and constitutive activation of the IL-12/STAT4 pathway in NK cells in Primary Biliary Cholangitis: A novel mechanism. In JOURNAL OF HEPATOLOGY Vol. 68 (pp. S457). doi:10.1016/S0168-8278(18)31158-9
IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells
Hydes, T., Noll, A., Salinas-Riester, G., Abuhilal, M., Armstrong, T., Hamady, Z., . . . Khakoo, S. I. (2018). IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells. IMMUNITY INFLAMMATION AND DISEASE, 6(1), 34-46. doi:10.1002/iid3.190
The UK-PBC Audit of Real-World Obeticholic Acid Use in Patients with Primary Biliary Cholangitis (PBC)
Trivedi, P., Hayden, J., Thorburn, D., Marshall, A., Aspinall, R., Dimmer, A., . . . Hirschfield, G. (2018). The UK-PBC Audit of Real-World Obeticholic Acid Use in Patients with Primary Biliary Cholangitis (PBC). In HEPATOLOGY Vol. 68 (pp. 1095A-1096A). Retrieved from https://www.webofscience.com/
2017
HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs
Thoens, C., Senff, T., Hydes, T. J., Manser, A. R., Heinemann, F. M., Heinold, A., . . . Timm, J. (2017). HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs. JOURNAL OF HEPATOLOGY, 67(3), 462-470. doi:10.1016/j.jhep.2017.03.040
THE NATIONAL EARLY WARNING SCORE (NEWS) ACCURATELY DISCRIMINATES THE RISK OF SERIOUS IN-HOSPITAL ADVERSE OUTCOMES IN PATIENTS WITH LIVER DISEASE
Hydes, T., Meredith, P., Schmidt, P., Smith, G., Prytherch, D., & Aspinall, R. (2017). THE NATIONAL EARLY WARNING SCORE (NEWS) ACCURATELY DISCRIMINATES THE RISK OF SERIOUS IN-HOSPITAL ADVERSE OUTCOMES IN PATIENTS WITH LIVER DISEASE. In GUT Vol. 66 (pp. A7). doi:10.1136/gutjnl-2017-314472.13
STAT4-associated natural killer cell tolerance following liver transplantation
Jamil, K. M., Hydes, T. J., Cheent, K. S., Cassidy, S. A., Traherne, J. A., Jayaraman, J., . . . Khakoo, S. I. (2017). STAT4-associated natural killer cell tolerance following liver transplantation. GUT, 66(2), 352-+. doi:10.1136/gutjnl-2015-309395
The National Early Warning Score accurately discriminates the risk of serious in-hospital adverse outcomes in patients with liver disease
Hydes, T. J., Meredith, P., Schmidt, P. E., Smith, G. B., Prytherch, D. R., & Aspinall, R. J. (2017). The National Early Warning Score accurately discriminates the risk of serious in-hospital adverse outcomes in patients with liver disease. In JOURNAL OF HEPATOLOGY Vol. 66 (pp. S578). doi:10.1016/S0168-8278(17)31577-5
2016
HLA-Bw4 80(T) and high HLA-Bw4 copy numbers in combination with KIR3DL1 are associated with superior immune control of HCV infection in people who inject drugs
Thöns, C., Senff, T., Hydes, T. J., Manser, A. R., Heinemann, F. M., Heinold, A., . . . Timm, J. (n.d.). HLA-Bw4 80(T) and high HLA-Bw4 copy numbers in combination with KIR3DL1 are associated with superior immune control of HCV infection in people who inject drugs. Zeitschrift für Gastroenterologie, 54(12), 1343-1404. doi:10.1055/s-0036-1597517
DISTINCT NATURAL KILLER CELL POPULATIONS IN THE HUMAN LIVER EXPRESS MARKERS OF NK CELL MEMORY AND MIGRATION
Hydes, T. J., AbuHilal, M., Armstrong, T., Hamady, Z., Primrose, J., Takhar, A., & Khakoo, S. (2016). DISTINCT NATURAL KILLER CELL POPULATIONS IN THE HUMAN LIVER EXPRESS MARKERS OF NK CELL MEMORY AND MIGRATION. In JOURNAL OF HEPATOLOGY Vol. 64 (pp. S528). doi:10.1016/S0168-8278(16)00932-6
KIR3DL1 IN COMBINATION WITH HLA-BW4-80T IS ASSOCIATED WITH SUPERIOR FUNCTIONALITY OF NK CELLS AND SPONTANEOUS IMMUNE CONTROL OF HCV INFECTION IN PEOPLE WHO INJECT DRUGS
Thoens, C., Senff, T., Hydes, T. J., Heinemann, F. M., Heinold, A., Heilmann, M., . . . Timm, J. (2016). KIR3DL1 IN COMBINATION WITH HLA-BW4-80T IS ASSOCIATED WITH SUPERIOR FUNCTIONALITY OF NK CELLS AND SPONTANEOUS IMMUNE CONTROL OF HCV INFECTION IN PEOPLE WHO INJECT DRUGS. In JOURNAL OF HEPATOLOGY Vol. 64 (pp. S515). doi:10.1016/S0168-8278(16)00900-4
2015
The interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways
Hydes, T. J., Moesker, B., Traherne, J. A., Ashraf, S., Alexander, G. J., Dimitrov, B. D., . . . Khakoo, S. I. (2015). The interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways. TISSUE ANTIGENS, 86(4), 267-275. doi:10.1111/tan.12650
Alcoholic liver disease - the extent of the problem and what you can do about it
Hazeldine, S., Hydes, T., & Sheron, N. (2015). Alcoholic liver disease - the extent of the problem and what you can do about it. CLINICAL MEDICINE, 15(2), 179-185. doi:10.7861/clinmedicine.15-2-179
Innate and adaptive genetic pathways in HCV infection
Buchanan, R., Hydes, T., & Khakoo, S. I. (2015). Innate and adaptive genetic pathways in HCV infection. TISSUE ANTIGENS, 85(4), 231-240. doi:10.1111/tan.12540
Natural killer cell maturation markers in the human liver and expansion of an NKG2C+KIR+ population
Hydes, T., Abuhilal, M., Armstrong, T., Primrose, J., Takhar, A., & Khakoo, S. (2015). Natural killer cell maturation markers in the human liver and expansion of an NKG2C+KIR+ population. LANCET, 385, 45. Retrieved from https://www.webofscience.com/
2014
Nitrofurantoin immune-mediated drug-induced liver injury: a serious complication of a commonly prescribed medication.
Hydes, T., Wright, M., Jaynes, E., & Nash, K. (2014). Nitrofurantoin immune-mediated drug-induced liver injury: a serious complication of a commonly prescribed medication.. BMJ case reports, 2014, bcr2013203136. doi:10.1136/bcr-2013-203136
2013
Synergism of Tapasin and Human Leukocyte Antigens in Resolving Hepatitis C Virus Infection
Ashraf, S., Nitschke, K., Warshow, U. M., Brooks, C. R., Kim, A. Y., Lauer, G. M., . . . Khakoo, S. I. (2013). Synergism of Tapasin and Human Leukocyte Antigens in Resolving Hepatitis C Virus Infection. HEPATOLOGY, 58(3), 881-889. doi:10.1002/hep.26415
District general hospital networks can provide safe and effective hepatitis C treatment: results of a 5-year audit
Hydes, T., Allen, H., Al-Shamma, S., Hovell, C., Sharer, N. M., & Williams, E. J. (2013). District general hospital networks can provide safe and effective hepatitis C treatment: results of a 5-year audit. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 25(8), 942-947. doi:10.1097/MEG.0b013e32835fba14
INTERACTION OF PROTECTIVE POLYMORPHISMS IN HCV: A COMPARISON OF SPONTANEOUS AND TREATMENT INDUCED RESOLUTION
Hydes, T., Ashraf, S., Alexander, G., & Khakoo, S. (2013). INTERACTION OF PROTECTIVE POLYMORPHISMS IN HCV: A COMPARISON OF SPONTANEOUS AND TREATMENT INDUCED RESOLUTION. In JOURNAL OF HEPATOLOGY Vol. 58 (pp. S139-S140). doi:10.1016/S0168-8278(13)60336-0
An evaluation of patient attitudes to colonoscopy and the importance of endoscopist interaction and the endoscopy environment to satisfaction and value
Mcentire, J., Sahota, J., Hydes, T., & Trebble, T. M. (2013). An evaluation of patient attitudes to colonoscopy and the importance of endoscopist interaction and the endoscopy environment to satisfaction and value. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 48(3), 366-373. doi:10.3109/00365521.2012.758768
2012
Innate immunity: a new chapter for hepatitis C.
Hydes, T., & Khakoo, S. I. (2012). Innate immunity: a new chapter for hepatitis C.. Annals of gastroenterology, 25(3), 232-240.
CRITICAL ILLNESS EARLY WARNING SCORES RETAIN ACCURACY IN PATIENTS WITH LIVER DISEASE-AN ANALYSIS OF 182 000 INPATIENT OBSERVATION SETS
Hydes, T., Schmidt, P., Smith, G. B., Prytherch, D., & Aspinall, R. J. (2012). CRITICAL ILLNESS EARLY WARNING SCORES RETAIN ACCURACY IN PATIENTS WITH LIVER DISEASE-AN ANALYSIS OF 182 000 INPATIENT OBSERVATION SETS. In GUT Vol. 61 (pp. A415). doi:10.1136/gutjnl-2012-302514d.289
DISTRICT GENERAL HOSPITAL NETWORKS CAN PROVIDE SAFE AND EFFECTIVE HEPATITIS C TREATMENT: RESULTS OF A 4-YEAR AUDIT
Hydes, T., Allen, H., Al-Shamma, S., Hovell, C., Sharer, N., & Williams, E. (2012). DISTRICT GENERAL HOSPITAL NETWORKS CAN PROVIDE SAFE AND EFFECTIVE HEPATITIS C TREATMENT: RESULTS OF A 4-YEAR AUDIT. In GUT Vol. 61 (pp. A144). doi:10.1136/gutjnl-2012-302514b.173
Subacute liver failure secondary to amyloid light-chain amyloidosis.
Hydes, T. J., & Aspinall, R. J. (2012). Subacute liver failure secondary to amyloid light-chain amyloidosis.. Gastroenterology & hepatology, 8(3), 205-208.
Highly accurate prediction of mortality in hospitalized patients with liver disease - an analysis of 182,000 inpatient datasets
Hydes, T. J., Schmidt, P. E., Smith, G. B., Meredith, P., Prytherch, D. R., & Aspinall, R. J. (2012). Highly accurate prediction of mortality in hospitalized patients with liver disease - an analysis of 182,000 inpatient datasets. In HEPATOLOGY Vol. 56 (pp. 1088A). Retrieved from https://www.webofscience.com/
Lean thinking transformation of the unsedated upper gastrointestinal endoscopy pathway improves efficiency and is associated with high levels of patient satisfaction
Hydes, T., Hansi, N., & Trebble, T. M. (2012). Lean thinking transformation of the unsedated upper gastrointestinal endoscopy pathway improves efficiency and is associated with high levels of patient satisfaction. BMJ QUALITY & SAFETY, 21(1), 63-69. doi:10.1136/bmjqs-2011-000173
2011
Liver International Image
Hydes, T. J., Hacking, C. N., & Aspinall, R. J. (2011). Liver International Image. LIVER INTERNATIONAL, 31(10), 1541. doi:10.1111/j.1478-3231.2011.02624.x
A survey of patients' attitudes to upper gastrointestinal endoscopy identifies the value of endoscopist-patient interactive factors.
Hydes, T., Yusuf, A., Pearl, D. S., & Trebble, T. M. (2011). A survey of patients' attitudes to upper gastrointestinal endoscopy identifies the value of endoscopist-patient interactive factors.. Frontline gastroenterology, 2(4), 242-248. doi:10.1136/fg.2011.004325
Redesigning services around patients and their doctors: the continuing relevance of lean thinking transformation
Trebble, T. M., & Hydes, T. (2011). Redesigning services around patients and their doctors: the continuing relevance of lean thinking transformation. CLINICAL MEDICINE, 11(4), 308-310. doi:10.7861/clinmedicine.11-4-308
2010
<i>Practice Pointer</i> Process mapping the patient journey: an introduction
Trebble, T. M., Hansi, N., Hydes, T., Smith, M. A., & Baker, M. (2010). <i>Practice Pointer</i> Process mapping the patient journey: an introduction. BMJ-BRITISH MEDICAL JOURNAL, 341. doi:10.1136/bmj.c4078
Undated
Risk of Type 2 Diabetes, Metabolic Dysfunction Associated Steatotic Liver Disease and Cardiovascular Disease in People Living with Polycystic Ovary Syndrome According to Disease Phenotype: An Analysis of Prospective Cohort and Multi-Organ Imaging Data from the UK Biobank
Henney, A. E., Gillespie, C. S., Lai, J. Y. M., Schofield, P., Riley, D., Caleyachetty, R., . . . Cuthbertson, D. J. (n.d.). Risk of Type 2 Diabetes, Metabolic Dysfunction Associated Steatotic Liver Disease and Cardiovascular Disease in People Living with Polycystic Ovary Syndrome According to Disease Phenotype: An Analysis of Prospective Cohort and Multi-Organ Imaging Data from the UK Biobank.